Publications by authors named "G Di Vito"

Background: The scalability of a blood-based sarcopenia assessment has generated interest in circulating markers that may enhance management strategies. Data regarding the relevance of brain derived neurotrophic factor (BDNF), a regulator of neuroplasticity, to sarcopenia in community-dwelling adults are scarce. We examined the association between plasma BDNF concentrations, sarcopenia and individual sarcopenia signatures in a well-characterised adult cohort.

View Article and Find Full Text PDF

Background: Population-specific reference values are needed to accurately contextualise age-related changes in body composition. This study aimed to a) establish age- and sex-specific reference values and cut-points for a range of dual-energy x-ray absorptiometry (DXA) derived metrics of lean mass (LM), fat mass (FM) and bone mineral density (BMD), across adulthood in a large adult cohort; and b) determine the association between DXA-derived body composition, body roundness index (BRI), and body mass index (BMI).

Methods: Cross-sectional data were collected from 10,033 men and women aged from 18 to 92 years.

View Article and Find Full Text PDF

Short-term unloading experienced following injury or hospitalisation induces muscle atrophy and weakness. The effects of exercise following unloading have been scarcely investigated. We investigated the functional and molecular adaptations to a resistance training (RT) programme following short-term unloading.

View Article and Find Full Text PDF

Reduced appetite with ageing is a key factor that may increase risk of undernutrition. The objective of this study is to determine the impact of innovative plant protein fibre (PPF) products within a personalised optimised diet (PD), a physical activity (PA) programme, and their combination on appetite, and other nutritional, functional and clinical outcomes in community-dwelling older adults in a multi-country randomised controlled intervention trial. One hundred and eighty community-dwelling adults (approximately sixty per trial centre in Germany, Ireland and Italy) aged 65 years and over will be recruited to participate in a 12-week, parallel-group, controlled trial.

View Article and Find Full Text PDF